Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-11 Sale | 2024-11-13 4:28 pm | Nuvation Bio Inc. | NUVB | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | 56,361 | $2.89 | $162,883 | 6,112,686 (Indirect Direct) | View |
| 2024-10-08 Purchase | 2024-10-10 4:33 pm | Nuvation Bio Inc. | NUVB | Mashal Robert Director | 100,000 | $2.2 | $220,000 | 100,000 (Indirect) | View |
| 2024-06-25 Purchase | 2024-06-26 4:31 pm | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 277,895 | $2.97 | $825,348 | 6,950,239 (Indirect) | View |
| 2024-06-20 Purchase | 2024-06-25 5:45 pm | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 500,000 | $2.9848 | $1,492,385 | 6,672,344 (Indirect) | View |
| 2024-06-11 Purchase | 2024-06-13 4:33 pm | Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director | 172,189 | $2.9043 | $500,089 | 172,189 (Indirect) | View |
| 2023-09-19 Purchase(A) | 2023-09-22 3:44 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 12,674,775 (Indirect) | View |
| 2023-02-19 Purchase | 2023-09-21 8:08 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 19,209,643 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-07 Option Award | 2024-10-09 4:09 pm | N/A 2034-10-06 | Nuvation Bio Inc. | NUVB | Sauvage Philippe Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 5:57 pm | N/A 2034-09-02 | Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director | 200,801 | $0 | 200,801 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 5:57 pm | N/A 2034-09-02 | Nuvation Bio Inc. | NUVB | FALBERG KATHRYN E Director | 200,801 | $0 | 200,801 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 5:56 pm | N/A 2034-09-02 | Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director | 200,801 | $0 | 200,801 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 5:55 pm | N/A 2034-09-02 | Nuvation Bio Inc. | NUVB | Bazemore Robert B Director | 200,801 | $0 | 200,801 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 4:46 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | 186,511 | $0 | 6,355,558 (Direct) | View |
| 2024-09-04 Conversion | 2024-09-05 4:46 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | 4,281,693 | $0 | 6,355,558 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 4:15 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 836,099 | $0 | 17,898,301 (Indirect) | View |
| 2024-09-04 Conversion | 2024-09-05 4:15 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 19,194,242 | $0 | 17,898,301 (Indirect) | View |
| 2024-05-24 Exercise | 2024-05-29 4:38 pm | N/A N/A | Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director | 293,203 | $1.74 | 679,494 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-29 4:38 pm | N/A 2030-07-21 | Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director | 659,947 | $0 | 679,494 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-29 4:38 pm | N/A N/A | Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director | 366,744 | $1.64 | 679,494 (Direct) | View |
| 2024-04-09 Option Award | 2024-04-11 9:01 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 6,172,344 | $0 | 4,183,002 (Indirect) | View |
| 2024-04-09 Option Award | 2024-04-11 6:31 pm | N/A 2034-04-08 | Nuvation Bio Inc. | NUVB | Sjogren Colleen Chief Commercial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2024-04-09 Option Award | 2024-04-11 6:30 pm | N/A 2028-12-31 | Nuvation Bio Inc. | NUVB | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | 2,804,715 | $0 | 2,804,715 (Direct) | View |
Ownership | 2024-04-02 4:31 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Sjogren Colleen Chief Commercial Officer | 0 | $0 | 25,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:25 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Wentworth Kerry CHIEF REGULATORY OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:24 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Markel Stacy CHIEF PEOPLE OFFICER | 500,000 | $0 | 510,591 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:22 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Makunje Moses SEE REMARKS | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:40 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Hanley David C. CHIEF TECHNICAL OPERATIONS | 500,000 | $0 | 512,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:33 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Hattersley Gary CHIEF SCIENTIFIC OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:27 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Liu Dongfang CHIEF MEDICAL OFFICER | 500,000 | $0 | 506,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:20 pm | N/A 2034-02-27 | Nuvation Bio Inc. | NUVB | Hung David PRESIDENT AND CEO 10% Owner | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2024-01-08 Option Award | 2024-01-10 4:22 pm | N/A 2034-01-07 | Nuvation Bio Inc. | NUVB | Mashal Robert Director | 741,179 | $0 | 741,179 (Direct) | View |
Ownership | 2023-11-27 4:09 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Makunje Moses See Remarks | 0 | $0 | 954,020 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 5:15 pm | N/A 2033-05-14 | Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director | 366,744 | $0 | 366,744 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 5:14 pm | N/A 2033-05-14 | Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director | 366,744 | $0 | 366,744 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 5:13 pm | N/A 2033-05-14 | Nuvation Bio Inc. | NUVB | FALBERG KATHRYN E Director | 366,744 | $0 | 366,744 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 5:12 pm | N/A 2033-05-14 | Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director | 366,744 | $0 | 366,744 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 5:04 pm | N/A 2033-05-14 | Nuvation Bio Inc. | NUVB | Bazemore Robert B Director | 366,744 | $0 | 366,744 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 6:02 pm | N/A 2033-02-27 | Nuvation Bio Inc. | NUVB | Markel Stacy Chief People Officer | 500,000 | $0 | 504,591 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 6:01 pm | N/A 2033-02-27 | Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner | 2,500,000 | $0 | 61,149,462 (Direct) | View |
| 2021-03-02 Other | 2023-03-02 6:01 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner | 368,408 | $0 | 61,149,462 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 6:00 pm | N/A 2033-02-27 | Nuvation Bio Inc. | NUVB | Hanley David C. Chief Technical Operations | 500,000 | $0 | 506,000 (Direct) | View |